A study examining the effect of the brolcizumab on neovascular age-related macular degeneration in Japanese with treat and extend
Not Applicable
Completed
- Conditions
- neovascular age-related macular degeneration
- Registration Number
- JPRN-UMIN000044374
- Lead Sponsor
- Jichi Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
Eye surgery within 3 months There are other disorders that cause vision loss History of vitreous surgery History of grid-like photocoagulation History of cerebrocardiovascular events within 6 months Adults who are judged to lack informed consent Doctor judges that it is not suitable for this study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method